BY55; NK1; NK28; CD160 Antigen; Natural killer cell receptor BY55
CD1-D; CD1A; R3G1; Antigen-presenting glycoprotein CD1d
CD1-D; CD1A; R3G1; Antigen-presenting glycoprotein CD1d
CD112; PVRL2; HVEB; PRR2; PVRR2; Herpesvirus Entry Mediator B; Herpes virus entry mediator B
MSMBBP; CRISP9; PSPBP; Microseminoprotein, Beta-Binding Protein; Protease Inhibitor 16; PSP94-binding protein; Cysteine-rich secretory protein 9
CD258; TR2; HVEML; LIGHT; LTg; Herpes virus entry mediator ligand; Herpesvirus entry mediator ligand
CD66c; NCA; CD66-C; CEAL; Non-Specific Cross Reacting Antigen; Normal cross-reacting antigen
CD25; IL2R-a; IL2-RA; IDDM10; IL2R; TCGFR; p55; TAC antigen
CD158F; KIR2DL5A; Killer cell immunoglobulin-like receptor 2DL5A
CD177; HNA2A; PRV1; HNA-2A; NB1 GP; Polycythemia Rubra Vera 1; Human neutrophil alloantigen 2a; Polycythemia rubra vera protein 1